Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RXRX | ZYME | ANAB | ||
| Company | Recursion Pharmaceuticals Inc Cl A | Zymeworks Inc | Anaptysbio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.99 | 22.02 | 52.98 | ||
| High | 3.04 | 23.00 | 55.28 | ||
| Low | 2.95 | 21.90 | 51.92 | ||
| Last | 3.04 | 22.71 | 55.04 | ||
| Change | +0.07 | +0.70 | +2.90 | ||
| Percent Change | +2.36% | +3.18% | +5.56% | ||
| Volume | 10,309,000 | 402,800 | 1,069,500 | ||
| 20-Day Average Volume | 22,757,721 | 459,290 | 825,335 | ||
| Previous | 2.97 | 22.01 | 52.14 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.28 | 24.40 | 58.51 | ||
| 20-Day Raw Stochastic | 16.00% | 14.70% | 25.14% | ||
| 20-Day Relative Strength | 44.66 | 42.11 | 47.21 | ||
| Weighted Alpha | -45.90 | +42.79 | +155.67 | ||
| Today's Opinion | 100% Sell | 40% Sell | 56% Buy | ||
| Yesterday's Opinion | 88% Sell | 40% Sell | 40% Buy | ||
| Last Month's Opinion | 24% Sell | 64% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.00% since 07/23/26 | -1.77% since 07/23/26 | +0.24% since 07/23/26 | ||
| Low | 2.86 on 07/28/26 | 21.90 on 07/30/26 | 50.51 on 07/29/26 | ||
| High | 3.13 on 07/27/26 | 23.69 on 07/24/26 | 55.90 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | -17.17% since 06/30/26 | -13.12% since 06/30/26 | -18.46% since 06/30/26 | ||
| Low | 2.84 on 07/20/26 | 21.90 on 07/30/26 | 49.71 on 07/21/26 | ||
| High | 4.09 on 07/06/26 | 27.41 on 07/09/26 | 70.91 on 07/14/26 | ||
| 3-Month | |||||
| %Chg | -12.14% since 04/30/26 | -17.54% since 04/30/26 | -16.26% since 04/30/26 | ||
| Low | 2.77 on 05/19/26 | 21.90 on 07/30/26 | 49.71 on 07/21/26 | ||
| High | 4.09 on 07/06/26 | 27.96 on 05/07/26 | 72.36 on 05/05/26 | ||
| 6-Month | |||||
| %Chg | -27.45% since 01/30/26 | +0.80% since 01/30/26 | +74.14% since 01/30/26 | ||
| Low | 2.77 on 05/19/26 | 21.90 on 07/30/26 | 31.17 on 02/05/26 | ||
| High | 4.28 on 02/03/26 | 29.75 on 04/27/26 | 72.36 on 05/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,573,818 | 1,607,236 | 1,543,761 | ||
| Shares Outstanding, K | 529,905 | 73,023 | 29,608 | ||
| Annual Sales, $M | 74,680,000 | 105,970,000 | 234,600,000 | ||
| Annual Net Income, $M | -644,760,000 | -81,130,000 | -13,230,000 | ||
| Last Qtr Sales, $M | 6,470,000 | 2,410,000 | 25,560,000 | ||
| Last Qtr Income, $M | -117,500,000 | -44,160,000 | -52,880,000 | ||
| 60-Month Beta | 1.00 | 1.13 | 0.68 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.22 on 05/06/26 | -0.59 on 05/07/26 | -1.84 on 05/12/26 | ||
| Latest Earnings Date | 08/04/26 | 08/06/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||